Published in Immunol Cell Biol on November 23, 2010
Human milk hyaluronan enhances innate defense of the intestinal epithelium. J Biol Chem (2013) 0.98
The Role of CD44 in Disease Pathophysiology and Targeted Treatment. Front Immunol (2015) 0.91
Triclosan alters antimicrobial and inflammatory responses of epithelial cells. Oral Dis (2013) 0.83
Transcription, translation, and function of lubricin, a boundary lubricant, at the ocular surface. JAMA Ophthalmol (2013) 0.83
Stimulation of TLR4 by LMW-HA induces metastasis in human papillary thyroid carcinoma through CXCR7. Clin Dev Immunol (2013) 0.80
The role of hyaluronan in innate defense responses of the intestine. Int J Cell Biol (2015) 0.78
Hyaluronan-phosphatidylethanolamine polymers form pericellular coats on keratinocytes and promote basal keratinocyte proliferation. Biomed Res Int (2014) 0.78
Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection. Microbes Infect (2016) 0.75
Role of HER2 in wound-induced breast carcinoma proliferation. Lancet (2003) 3.40
FOXP3 expression and overall survival in breast cancer. J Clin Oncol (2009) 2.71
Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology (2008) 1.62
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer. J Clin Oncol (2003) 1.61
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res (2008) 1.61
Apoptosis induction by trastuzumab: possible role of the core biopsy intervention. J Clin Oncol (2005) 1.49
Combination of metronomic gimatecan and CpG-oligodeoxynucleotides against an orthotopic pancreatic cancer xenograft. Cancer Biol Ther (2008) 1.47
Degranulation of paneth cells via toll-like receptor 9. Am J Pathol (2004) 1.36
Membrane shape at the edge of the dynamin helix sets location and duration of the fission reaction. Cell (2012) 1.34
Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia. J Histochem Cytochem (2009) 1.29
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer. J Immunol (2006) 1.26
Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol (2007) 1.15
Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol (2008) 1.14
CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma. Cancer Res (2008) 1.14
Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol (2006) 1.13
The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons. Hum Mol Genet (2004) 1.09
Critical role of TLR9 in acute graft-versus-host disease. J Immunol (2008) 1.03
Proximity of TPR and NTRK1 rearranging loci in human thyrocytes. Cancer Res (2005) 1.01
HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. Clin Cancer Res (2002) 1.00
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effects. Cancer Res (2011) 1.00
HER2 as a target for breast cancer therapy. Expert Opin Biol Ther (2010) 0.99
Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. Clin Diagn Lab Immunol (2005) 0.98
Mechanoregulation of intracellular Ca2+ in human autosomal recessive polycystic kidney disease cyst-lining renal epithelial cells. Am J Physiol Renal Physiol (2008) 0.98
Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J Immunol (2004) 0.97
CpG-oligodeoxynucleotides induce mobilization of hematopoietic progenitor cells into peripheral blood in association with mouse KC (IL-8) production. J Cell Physiol (2005) 0.97
Fluid shear stress induces renal epithelial gene expression through polycystin-2-dependent trafficking of extracellular regulated kinase. Nephron Physiol (2010) 0.97
Lentiviral gene delivery to CNS by spinal intrathecal administration to neonatal mice. J Gene Med (2006) 0.96
FOXP3 expression in tumor cells and implications for cancer progression. J Cell Physiol (2013) 0.95
Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy. Clin Cancer Res (2008) 0.93
Induction of Paneth cell degranulation by orally administered Toll-like receptor ligands. J Cell Physiol (2012) 0.93
Therapeutic synergism of gemcitabine and CpG-oligodeoxynucleotides in an orthotopic human pancreatic carcinoma xenograft. Cancer Res (2005) 0.93
Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors. Cell Oncol (2010) 0.93
Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses. J Leukoc Biol (2007) 0.91
Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. PLoS One (2012) 0.91
Activity and resistance of trastuzumab according to different clinical settings. Cancer Treat Rev (2011) 0.90
Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther (2009) 0.89
Role of proliferation in HER2 status predicted response to doxorubicin. Int J Cancer (2003) 0.89
Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic mice. Cancer Res (2006) 0.88
Human cytomegalovirus regulates surface expression of the viral protein UL18 by means of two motifs present in the cytoplasmic tail. J Immunol (2008) 0.87
Cross-talk among Toll-like receptors and their ligands. Int Immunol (2008) 0.86
GM-CSF/IL-3/IL-5 receptor common beta chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells. J Transl Med (2008) 0.86
Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int Immunol (2008) 0.86
Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice. J Immunol (2002) 0.86
Doxorubicin-induced alopecia is associated with sebaceous gland degeneration. J Invest Dermatol (2006) 0.85
Sodium-dependent glucose transporter-1 as a novel immunological player in the intestinal mucosa. J Immunol (2008) 0.85
High efficacy of CpG-ODN, cetuximab and cisplatin combination for very advanced ovarian xenograft tumors. J Transl Med (2013) 0.85
Characterization of human metapneumovirus infection of myeloid dendritic cells. Virology (2006) 0.85
Cilium, centrosome and cell cycle regulation in polycystic kidney disease. Biochim Biophys Acta (2011) 0.85
Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia. Am J Physiol Renal Physiol (2012) 0.83
Ascites regression and survival increase in mice bearing advanced-stage human ovarian carcinomas and repeatedly treated intraperitoneally with CpG-ODN. J Immunother (2010) 0.82
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patients. Int J Cancer (2003) 0.82
Intestinal glucose uptake protects liver from lipopolysaccharide and D-galactosamine, acetaminophen, and alpha-amanitin in mice. Am J Pathol (2009) 0.82
Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu. J Immunother (2008) 0.81
Maspin influences response to doxorubicin by changing the tumor microenvironment organization. Int J Cancer (2013) 0.81
Psychopathological similarities and differences between obese patients seeking surgical and non-surgical overweight treatments. Eat Weight Disord (2013) 0.80
Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases. Int J Cancer (2013) 0.80
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. Breast Cancer Res Treat (2011) 0.80
Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells. MAbs (2012) 0.80
Enhanced antitumour efficacy of gimatecan in combination with Bcl-2 antisense oligonucleotide in human melanoma xenografts. Eur J Cancer (2005) 0.80
Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation. PLoS One (2013) 0.79
Matured human monocyte-derived dendritic cells (MoDCs) induce expansion of CD4+CD25+FOXP3+ T cells lacking regulatory properties. Immunol Lett (2008) 0.79
Neoplastic and stromal cells contribute to an extracellular matrix gene expression profile defining a breast cancer subtype likely to progress. PLoS One (2013) 0.78
Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells? Oncoimmunology (2012) 0.78
EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas. J Cell Physiol (2013) 0.78
Most immunoglobulin heavy chain switch mu rearrangements in B-cell chronic lymphocytic leukemia are internal deletions. FEBS Lett (2002) 0.77
Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis. Mol Cancer (2014) 0.77
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2-specific T lymphocytes but do not lead to a protective tumor-specific memory response. Cancer Immunol Immunother (2004) 0.77
Desmocollin 1 expression and desmosomal remodeling during terminal differentiation of human anagen hair follicle: an electron microscopic study. Exp Dermatol (2004) 0.77
Aerosol Delivery in the Treatment of Lung Cancer. Curr Cancer Drug Targets (2015) 0.77
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact. Clin Cancer Res (2008) 0.77
Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness. Eur J Cancer (2006) 0.77
Molecular phenotype distinguishes two subsets of gastric low-grade mucosa-associated lymphoid tissue lymphomas. Lab Invest (2002) 0.76
Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C. Dig Liver Dis (2013) 0.76
Tumor microenvironment and the immune response. Surg Oncol Clin N Am (2007) 0.76
The HER2 World: Better Treatment Selection for Better Outcome. J Natl Cancer Inst Monogr (2011) 0.76
Dansyl C-glucoside as a novel agent against endotoxic shock. ChemMedChem (2010) 0.76
Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA. FASEB J (2002) 0.76